Overview
The Silverstein Foundation is a philanthropic organization based in New York, NY, with a focus on funding initiatives in various cities including Arrayyan, Cambridge, New York, Oxford, San Carlos, Tel Aviv-Yafo, and Toronto. Despite having assets of $320,724, the foundation's expenses significantly exceed its revenue, with expenses totaling $1,782,655 against a revenue of $625,714. The foundation is led by Jonathan Silverstein, who serves as the President and Chair of the Board, and Natalie Silverstein, the Vice President and Secretary. Both serve without compensation. The foundation does not specify particular subject areas of focus in its funding activities.
Focus Areas
Geographic Focus
See real-time funding availability
View funding probability data
View detailed grant size data
Example compatibility analysis for demonstration purposes
Match Score measures the compatibility between your organization and this funder based on focus areas alignment (92%), geographic location preferences (85%), previous grantees similarity (88%), grant size match (78%), application process compatibility (73%), and timeline compatibility (80%).
Financials
in 2024, compared to $1,476,308 in 2023
6 grants awarded in 2024
Of total expenses go to programs
Grants
Amount | Recipient | Purpose | Location | Year | |
|---|---|---|---|---|---|
| $1,372,500 | THE NEW YORK STEM CELL FOUNDATION | DRUG DISCOVERY FOR PARKINSON'S WITH GBA. | 619 WEST 54TH STREET NEW YORK, NY US | 2023 | |
| $627,500 | THE NEW YORK STEM CELL FOUNDATION | DRUG DISCOVERY FOR PARKINSON'S WITH GBA | 619 WEST 54TH STREET NEW YORK, NY US | 2024 | |
| $276,000 | TEL AVIV SOURASKY MEDICAL CENTER | THE ROLE OF THE IMMUNE SYSTEM IN GLUOCEREBROSIDASE (GBA)-PD: A CSF AND PBMC STUDY | WEIZMANN ST 6 TEL AVIVYAFO, IS | 2024 | |
| $250,000 | SUNNYBROOK RESEARCH INSTITUTE | A PHASE I/II STUDY FOR BILATERAL PUTAMENAL DELIVERY OF RECOMBINANT GLUCOCEREBROSIDASE IN PATIENTS WI... | 2075 BAYVIEW AVENUE TORONTO, CA | 2024 | |
| $225,000 | LYSOWAY THERAPEUTICS | EVALUATING THE THERAPEUTIC EFFECTS OF TRPML1 AND TMEM175 AGONISTS ON GBA-DEFICIENT PARKINSON'S DISEA... | 125 CAMBRIDGE PARK DRIVE SUITE 301 CAMBRIDGE, MA US | 2023 | |
| $225,000 | CURASEN THERAPEUTICS | GENOTYPING AND BIOMARKER ANALYSES IN CLINICAL STUDY | 930 BRITTAN AVENUE SUITE 306 SAN CARLOS, CA US | 2024 | |
| $200,000 | MICHAEL J FOX FOUNDATION MODAG | FOLLOW-UP STUDY OF A DRUG (ANLE138B) - GOAL IS TO STOP THE PARKINSON'S PROTEIN ALPHA-SYNUCLEIN (A-SY... | GRAND CENTRAL STATION PO BOX 4777 NEW YORK, NY US | 2023 | |
| $195,000 | THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD | SUPPORT ONE MOVEMENT DISORDERS FELLOW FOR A TWO-YEAR PERIOD WHO HAS A FOCUS ON GBA-PARKINSON'S DISEA... | WELLINGTON SQUARE OXFORD, UK | 2024 | |
| $190,000 | HAMAD BIN KHALIFA UNIVERSITY | THERAPEUTIC NANOBODY DEVELOPMENT FOR TARGETING ALPHA-SYNUCLEIN AGGREGATION IN PARKINSON'S DISEASE, W... | EDUCATION CITY - GATE 8 ARRAYYAN, QA | 2024 |
People
Compensation data from most recent available 990 forms
| Title | |||
|---|---|---|---|
JS JONATHAN SILVERSTEIN | PRESIDENT / SECRETARY | $0 | 2022 |
NS NATALIE SILVERSTEIN | VICE PRESIDENT / TREASURER | $0 | 2022 |
GL GEOFFREY LEVIN | BOARD MEMBER | $0 | 2022 |
JS JONATHAN SILVERSTEIN | PRESIDENT / SECRETARY | $0 | 2023 |
NS NATALIE SILVERSTEIN | VICE PRESIDENT / TREASURER | $0 | 2023 |
JONATHAN SILVERSTEIN
PRESIDENT / SECRETARY
NATALIE SILVERSTEIN
VICE PRESIDENT / TREASURER
GEOFFREY LEVIN
BOARD MEMBER
JONATHAN SILVERSTEIN
PRESIDENT / SECRETARY
NATALIE SILVERSTEIN
VICE PRESIDENT / TREASURER
Opportunities
Opportunities Coming Soon
We're building a comprehensive database of funding opportunities, application deadlines, and success insights to help you win more grants.
Application Deadlines
Real-time tracking of funding opportunities and deadlines
Active RFPs
Current funding opportunities tailored to your focus areas
Success Insights
Data-driven tips to improve application success rate
Be the first to know when opportunities become available.
Ready to streamline your grant process?
Join thousands of organizations using Grantable to write better grants, manage deadlines, and secure more funding.
Financial data sourced from IRS 990 forms via ProPublica Nonprofit Explorer
View on ProPublica Nonprofit ExplorerLast updated on December 15, 2024